Klin Farmakol Farm. 2019;33(2):20-23 | DOI: 10.36290/far.2019.011

Peripheral muscle relaxants in modern anaesthesiology

Petr Štourač, Martina Kosinová
Klinika dětské anesteziologie a resuscitace, Fakultní nemocnice Brno, Lékařská fakulta Masarykovy univerzity, Brno

Peripheral muscle relaxants are an integral part of modern anaesthesiology. They ensure, in particular, facilitation of the surgical procedure and good conditions for intubation. Unlike in the past, when attention in terms of neuromuscular blockade was paid to these very aspects, there now predominates an interest in monitoring the depth of neuromuscular blockade during the course of the procedure and its reversal. Active reversal of neuromuscular blockade in the presence of objective monitoring of the recovery rate is an important safety factor of muscle relaxant use. The article deals with the current trends in the use of peripheral muscle relaxants.

Keywords: general anaesthesia; muscle relaxation; peripheral muscle relaxants; reversal of neuromuscular blockade; sugammadex

Published: July 10, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štourač P, Kosinová M. Peripheral muscle relaxants in modern anaesthesiology. Klin Farmakol Farm. 2019;33(2):20-23. doi: 10.36290/far.2019.011.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Griffith H, Johnson GE. The Use of Curare in General Anesthesia. Anesthesiology, 1942. 3(4): 418-420. doi:10.1097/00000542-194207000-00006. Go to original source...
    2. Gjsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005 Oct; 103(4): 695-703. Go to original source... Go to PubMed...
    3. Adamus M, Černý V, Cvachovec K, et al. Zásady bezpečné anesteziologické péče. Anesteziologie a intenzivní medicína, 2018, 29(2): 107-110.
    4. Adamus M, Herold I, Cvachovec K, Ševčík P, Černý V. Svalová relaxace během celkové anestezie v České republice 2010 - Jednodenní prospektivní observační dotazníková studie. Anesteziologie a intenzivní medicína. 2011; 22(2): 82-99.
    5. Klucka J, Kosinova M, Krikava I, Stoudek R, Toukalkova M, Stourac P. Residual Neuromuscular Blockade in Paediatric Anaesthesia. British Journal of Anaesthesia. 2019. Jan; 122(1): e1-e2. doi: 10.1016/j.bja.2018. 10. 001 Go to original source... Go to PubMed...
    6. Fortier LP, McKeen D, Turner K, et al. The RECITE study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015; 121: 366-372. Go to original source... Go to PubMed...
    7. Claudius C, Garvey LH, Viby-Mogensen J. The undesirable effects of neuromuscular blocking drugs. Anaesthesia 2009; 64(Suppl. 1): 10-21. Go to original source... Go to PubMed...
    8. Eikermann M, Fassbender P, Malhotra A, et al. Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. Anesthesiology 2007; 107: 621-629. Go to original source... Go to PubMed...
    9. Beemer GH, Bjorksten AR, Dawson PJ, et al. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. Br J Anaesth 1991; 66: 469-475. Go to original source... Go to PubMed...
    10. Stourac P, Krikava I, Seidlova J, Strazevska E, Huser M, Hruban L, Janku P, Gal R. Sugammadex in a parturient with myotonic dystrophy. Br J Anaesth. 2013 Apr; 110(4): 657-658. doi: 10.1093/bja/aet037. Go to original source... Go to PubMed...
    11. Saricicek V, Sahin L, Bulbul F, Ucar S, Sahin M. Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression? J ECT. 2014 Mar; 30(1): 30-34. doi: 10.1097/YCT.0b013e3182972bd2. Go to original source... Go to PubMed...
    12. Lee C. Goodbye suxamethonium! Anaesthesia. 2009 Mar; 64(Suppl 1): 73-81. doi: 10.1111/j.1365-2044.2008.05873.x. Go to original source... Go to PubMed...
    13. Stourac P, Adamus M, Seidlova D, et al. Low-dose or high-dose rocuronium reversed with neostigmine or sugammadex for cesarean delivery anesthesia: A randomized controlled non-inferiority trial of time to tracheal intubation and extubation. Anesth Analg. 2016 May; 122(5): 1536-1545. doi: 10.1213/ANE.0000000000001197. Go to original source... Go to PubMed...
    14. Kosinova M, Stourac P, Adamus M, et al. Rocuronium versus suxamethonium for rapid sequence induction of general anaesthesia for caesarean section: influence on neonatal outcomes. Int J Obstet Anesth. 2017 Nov; 32: 4-10. doi: 10.1016/j.ijoa.2017. 05. 001. Epub 2017 May 10. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.